Adimmune Corp (Taiwan) Insiders
| 4142 Stock | TWD 21.20 0.10 0.47% |
Adimmune Corp employs about 36 people. The company is managed by 8 executives with a total tenure of roughly 12 years, averaging almost 1.0 years of service per executive, having 4.5 employees per reported executive. Recap of Adimmune Corp's management performance can provide insight into the venture performance.
| Fei Pan Executive Chief Legal Affairs Officer |
| ChinChuan Chang Insider COO RD |
Adimmune |
Adimmune Corp Management Team Effectiveness
The company has return on total asset (ROA) of 0.0139 % which means that it generated a profit of $0.0139 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0655 %, meaning that it generated $0.0655 on every $100 dollars invested by stockholders. Adimmune Corp's management efficiency ratios could be used to measure how well Adimmune Corp manages its routine affairs as well as how well it operates its assets and liabilities.Adimmune Corp Workforce Comparison
Adimmune Corp is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 904,194. Adimmune Corp adds roughly 36.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.21 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08. Adimmune Corp Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Adimmune Corp Price Series Summation is a cross summation of Adimmune Corp price series and its benchmark/peer.
Adimmune Corp Notable Stakeholders
An Adimmune Corp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Adimmune Corp often face trade-offs trying to please all of them. Adimmune Corp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Adimmune Corp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Fei Pan | Chief Legal Affairs Officer | Profile | |
| ChinChuan Chang | COO RD | Profile | |
| LiYa Tang | Director Center | Profile | |
| ChihHsiang Leng | Head Division | Profile | |
| ChungCheng Liu | GM Pres | Profile | |
| YinTeng Chang | Chief Officer | Profile | |
| MBA MD | Chief Officer | Profile | |
| ChiHsien Chan | CEO Chairman | Profile |
About Adimmune Corp Management Performance
The success or failure of an entity such as Adimmune Corp often depends on how effective the management is. Adimmune Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Adimmune management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Adimmune management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Adimmune Corporation manufactures and sells human vaccines in Taiwan. Adimmune Corporation was founded in 1965 and is based in Taichung City, Taiwan. ADIMMUNE CORPORATION operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange. It employs 384 people.
Please note, the imprecision that can be found in Adimmune Corp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Adimmune Corp. Check Adimmune Corp's Beneish M Score to see the likelihood of Adimmune Corp's management manipulating its earnings.
Adimmune Corp Workforce Analysis
Traditionally, organizations such as Adimmune Corp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Adimmune Corp within its industry.Adimmune Corp Manpower Efficiency
Return on Adimmune Corp Manpower
| Revenue Per Employee | 45.6M | |
| Revenue Per Executive | 205.1M | |
| Net Income Per Employee | 1.2M | |
| Net Income Per Executive | 5.4M | |
| Working Capital Per Employee | 28.2M | |
| Working Capital Per Executive | 127.1M |
Additional Tools for Adimmune Stock Analysis
When running Adimmune Corp's price analysis, check to measure Adimmune Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adimmune Corp is operating at the current time. Most of Adimmune Corp's value examination focuses on studying past and present price action to predict the probability of Adimmune Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adimmune Corp's price. Additionally, you may evaluate how the addition of Adimmune Corp to your portfolios can decrease your overall portfolio volatility.